Clinical Trial Update: Adoptive Autologous iNKT Cells for the Treatment of Progressed Hepatocellular Carcinoma Continuing on PD-1 Inhibitor Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adoptive autologous iNKT cells for progressed hepatocellular carcinoma in patients continuing PD-1 inhibitor therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 inhibitor
• adoptive autologous iNKT cells

Snippet

Sponsor: Beijing YouAn Hospital | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN